Eckert & Ziegler SE Stock price

Equities

EUZ

DE0005659700

Pharmaceuticals

Real-time Estimate Tradegate 09:16:06 2024-03-28 am EDT 5-day change 1st Jan Change
37.58 EUR +0.97% Intraday chart for Eckert & Ziegler SE -5.78% -9.25%
Sales 2024 * 268M 289M Sales 2025 * 294M 318M Capitalization 775M 837M
Net income 2024 * 31M 33.47M Net income 2025 * 34M 36.71M EV / Sales 2024 * 2.74 x
Net cash position 2024 * 41.5M 44.81M Net cash position 2025 * 37.9M 40.92M EV / Sales 2025 * 2.5 x
P/E ratio 2024 *
24.8 x
P/E ratio 2025 *
22.3 x
Employees 1,062
Yield 2024 *
1.34%
Yield 2025 *
1.34%
Free-Float 66.95%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.40%
1 week-6.13%
Current month-11.81%
1 month-13.00%
3 months-10.24%
6 months+19.14%
Current year-9.59%
More quotes
1 week
36.82
Extreme 36.82
40.44
1 month
35.24
Extreme 35.24
43.22
Current year
35.24
Extreme 35.24
46.90
1 year
28.92
Extreme 28.92
51.70
3 years
28.92
Extreme 28.92
141.40
5 years
17.98
Extreme 17.975
141.40
10 years
4.15
Extreme 4.1525
141.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 16-12-31
Founder 55 96-12-31
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 71 18-12-31
Founder 55 96-12-31
Director/Board Member 71 19-05-28
More insiders
Date Price Change Volume
24-03-28 37.52 +0.81% 18 375
24-03-27 37.22 -0.48% 52,884
24-03-26 37.4 -1.01% 73,231
24-03-25 37.78 +1.23% 53,667
24-03-22 37.32 -6.18% 222,736

Delayed Quote Xetra, March 28, 2024 at 04:04 am EDT

More quotes
Eckert & Ziegler Strahlen und Medizintechnik AG is a Germany-based provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
37.22 EUR
Average target price
60 EUR
Spread / Average Target
+61.20%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Eckert & Ziegler SE - Xetra